These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7621437)

  • 1. Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors.
    Canti G; Lattuada D; Morelli S; Nicolin A; Cubeddu R; Taroni P; Valentini G
    Cancer Lett; 1995 Jul; 93(2):255-9. PubMed ID: 7621437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors.
    Canti G; Nicolin A; Cubeddu R; Taroni P; Bandieramonte G; Valentini G
    Cancer Lett; 1998 Mar; 125(1-2):39-44. PubMed ID: 9566694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light.
    Canti G; Lattuada D; Nicolin A; Taroni P; Valentini G; Cubeddu R
    Anticancer Drugs; 1994 Aug; 5(4):443-7. PubMed ID: 7949249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.
    Ganapathi R; Grabowski D; Sweatman TW; Seshadri R; Israel M
    Br J Cancer; 1989 Dec; 60(6):819-26. PubMed ID: 2605093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y
    Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo absorption spectrum of disulphonated aluminium phthalocyanine in a murine tumour model.
    Cubeddu R; Canti G; Musolino M; Pifferi A; Taroni P; Valentini G
    J Photochem Photobiol B; 1996 Jul; 34(2-3):229-35. PubMed ID: 8810541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo effects of photodynamic therapy on murine malignant melanoma.
    Haddad R; Blumenfeld A; Siegal A; Kaplan O; Cohen M; Skornick Y; Kashtan H
    Ann Surg Oncol; 1998; 5(3):241-7. PubMed ID: 9607626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM
    Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action spectrum of photoactivated phthalocyanine AIS2Pc in tumor bearing mice.
    Canti G; Lattuada D; Leroy E; Cubeddu R; Taroni P; Valentini G
    Anticancer Drugs; 1992 Apr; 3(2):139-42. PubMed ID: 1525391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA; Wodinsky I
    Cancer; 1983 Feb; 51(4):600-5. PubMed ID: 6401590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of doxorubicin and cisplatin resistance in vivo in murine leukemias by the calcium antagonist RO 11-2933.
    Mazzoni A; Canti G
    Sel Cancer Ther; 1990; 6(4):167-76. PubMed ID: 2094936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.
    Harrison SD; Brockman RW; Trader MW; Laster WR; Griswold DP
    Invest New Drugs; 1987 Dec; 5(4):345-51. PubMed ID: 3436739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo.
    Harrison SD; Plowman J; Dykes DJ; Waud WR; Griswold DP
    Cancer Chemother Pharmacol; 1990; 25(6):425-9. PubMed ID: 2311170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.
    Lippman MM; Laster WR; Abbott BJ; Venditti J; Baratta M
    Cancer Res; 1975 Apr; 35(4):939-45. PubMed ID: 1116151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-laser light source for photodynamic therapy: in vitro effects on normal and malignant cells.
    Kashtan H; Haddad R; Greenberg R; Skornick Y; Kaplan O
    J Med; 2002; 33(1-4):93-104. PubMed ID: 12939108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical antitumor activity of bizelesin in mice.
    Carter CA; Waud WR; Li LH; DeKoning TF; McGovren JP; Plowman J
    Clin Cancer Res; 1996 Jul; 2(7):1143-9. PubMed ID: 9816280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
    Watanabe M; Komeshima N; Nakajima S; Tsuruo T
    Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.